Sofosbuvir Impurity 4 | CAS 1621160-31-3 - Request Quote
Sofosbuvir Impurity 4
| SZ CAT No: | SZ-S010027 |
| CAS No | 1621160-31-3 |
| Mol.F. | C20H18ClFO5 |
| Mol.Wt. | 392.8 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sofosbuvir Impurity 4 is chemically ((2R,3R,4R)-3-(Benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate. Sofosbuvir Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sofosbuvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1621160-31-3
Purchase 1621160-31-3
Order 1621160-31-3
Enquire 1621160-31-3
price of 1621160-31-3
1621160-31-3 Supplier
1621160-31-3 Manufacturer
1621160-31-3 Exporter
buy high quality Sofosbuvir Impurity 4
Purchase Sofosbuvir Impurity 4
Sofosbuvir Impurity 4 suppliers
Sofosbuvir Impurity 4 manufacturers
Sofosbuvir Impurity 4 price
Order Sofosbuvir Impurity 4
Enquire Sofosbuvir Impurity 4
Sofosbuvir Impurity 4 cost
Sofosbuvir Impurity 4 Supplier
Sofosbuvir Impurity 4 Distributor
Sofosbuvir Impurity 4 for Method Validation
Sofosbuvir Reference Standard
Sofosbuvir Impurity 4 for ANDA Filing
Sofosbuvir Impurity 4 for Forced Degradation Studies
Sofosbuvir Impurity 4 Identification Standards
Sofosbuvir Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.